Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Yongpeng Wei, Guangyao Li, Zhuo Wang, Kewen Qian, Shuyi Zhang, Lingling Zhang, Changhai Lei & Shi Hu. (2024) Development and characterization of a novel neutralizing scFv vectored immunoprophylaxis against botulinum toxin type A. Journal of Drug Targeting 32:2, pages 213-222.
Read now
Read now
Carl Mieczkowski, Xuejin Zhang, Dana Lee, Khanh Nguyen, Wei Lv, Yanling Wang, Yue Zhang, Jackie Way & Jean-Michel Gries. (2023) Blueprint for antibody biologics developability. mAbs 15:1.
Read now
Read now
Reza Maleki, Azam Rahimpour & Masoumeh Rajabibazl. (2023) Construction and evaluation of wild and mutant ofatumumab scFvs against the human CD20 antigen. Preparative Biochemistry & Biotechnology 53:3, pages 239-246.
Read now
Read now
David Prihoda, Jad Maamary, Andrew Waight, Veronica Juan, Laurence Fayadat-Dilman, Daniel Svozil & Danny A. Bitton. (2022) BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning. mAbs 14:1.
Read now
Read now
Dustin Hicks, Carly Baehr, Pedro Silva-Ortiz, Aaron Khaimraj, Diego Luengas, Fatima A. Hamid & Marco Pravetoni. (2022) Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Josefa Dela Cruz Chuh, MaryAnn Go, Yvonne Chen, Jun Guo, Hanine Rafidi, Danielle Mandikian, Yonglian Sun, Zhonghua Lin, Kellen Schneider, Pamela Zhang, Rajesh Vij, Danielle Sharpnack, Pamela Chan, Cecile de la Cruz, Jack Sadowsky, Dhaya Seshasayee, James T. Koerber, Thomas H. Pillow, Gail D. Phillips, Rebecca K Rowntree, C. Andrew Boswell, Katherine R. Kozak, Andrew G. Polson, Paul Polakis, Shang-Fan Yu, Peter S. Dragovich & Nicholas J. Agard. (2021) Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response. mAbs 13:1.
Read now
Read now
Sadia Sikder, Vrinda Gote, Meshal Alshamrani, Jeff Sicotte & Dhananjay Pal. (2019) Long-term delivery of protein and peptide therapeutics for cancer therapies. Expert Opinion on Drug Delivery 16:10, pages 1113-1131.
Read now
Read now
Rafaela L Fogaça, Larissa M Alvarenga, Thiago D Woiski, Alessandra Becker-Finco, Kadima N Teixeira, Sabrina K Silva, Rosana N de Moraes, Lúcia de Noronha, Magali Noiray, Bonald C de Figueiredo, Philippe Billiald & Juliana de Moura. (2019) Biomolecular Engineering of Antidehydroepiandrosterone Antibodies: A New Perspective in Cancer Diagnosis and Treatment Using Single-Chain Antibody Variable Fragment. Nanomedicine 14:6, pages 689-705.
Read now
Read now
Arsham Banisadr, Yaghoub Safdari, Anvarsadat Kianmehr & Mahdieh Pourafshar. (2018) Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cells. Human Vaccines & Immunotherapeutics 14:4, pages 856-863.
Read now
Read now
Jared L. Spidel, Earl F. Albone, Xin Cheng, Benjamin Vaessen, Sara Jacob, Andrew Z. Milinichik, Arielle Verdi, J. Bradford Kline & Luigi Grasso. (2017) Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxins. mAbs 9:6, pages 907-915.
Read now
Read now
Alexander Bujotzek, Florian Lipsmeier, Seth F Harris, Jörg Benz, Andreas Kuglstatter & Guy Georges. (2016) VH-VL orientation prediction for antibody humanization candidate selection: A case study. mAbs 8:2, pages 288-305.
Read now
Read now
Yoonjoo Choi, Casey Hua, Charles L Sentman, Margaret E Ackerman & Chris Bailey-Kellogg. (2015) Antibody humanization by structure-based computational protein design. mAbs 7:6, pages 1045-1057.
Read now
Read now
Michael F Criscitiello. (2014) What the shark immune system can and cannot provide for the expanding design landscape of immunotherapy. Expert Opinion on Drug Discovery 9:7, pages 725-739.
Read now
Read now
Articles from other publishers (82)
Dong Li, Fabrizio Pucci & Marianne Rooman. (2024) Prediction of Paratope–Epitope Pairs Using Convolutional Neural Networks. International Journal of Molecular Sciences 25:10, pages 5434.
Crossref
Crossref
Gemma L. Gordon, Matthew I. J. Raybould, Ashley Wong & Charlotte M. Deane. (2024) Prospects for the computational humanization of antibodies and nanobodies. Frontiers in Immunology 15.
Crossref
Crossref
Jonathan Parkinson & Wei Wang. (2024) For antibody sequence generative modeling, mixture models may be all you need. Bioinformatics 40:5.
Crossref
Crossref
George Buchlis & Boris Gorovits. 2024. Drug Development for Gene Therapy. Drug Development for Gene Therapy
291
315
.
Eugenio Gallo. (2024) The rise of big data: deep sequencing-driven computational methods are transforming the landscape of synthetic antibody design. Journal of Biomedical Science 31:1.
Crossref
Crossref
Ziyi Liu, Dokyun Kim, Seokmin Kang & Jae U. Jung. (2024) A Detailed Protocol for Constructing a Human Single-Chain Variable Fragment (scFv) Library and Downstream Screening via Phage Display. Methods and Protocols 7:1, pages 13.
Crossref
Crossref
Jiachen Wei, Junxian Li, Fanjie Zong, Zhi‐Xiong Xiao & Yang Cao. (2024) Computational Analysis of B‐Cell Receptor (BCR) Immune Repertoires with Abalign. Current Protocols 4:2.
Crossref
Crossref
Marina E. Kirkland, Stephanie Patfield, Anna C. Hughes, Bradley Hernlem & Xiaohua He. (2024) A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy. Antimicrobial Agents and Chemotherapy 68:1.
Crossref
Crossref
Weiliang Zhuang, Wei Zhang, Liping Xie, Lei Wang, Yuan Li, Ziyu Wang, Ao Zhang, Haitao Qiu, Jun Feng, Baohong Zhang & Youjia Hu. (2023) Generation and Characterization of SORT1-Targeted Antibody–Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor. International Journal of Molecular Sciences 24:24, pages 17631.
Crossref
Crossref
Matthew Lohman, Hannah Rowe,Peter R. Andreana. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics
201
221
.
Evgeny L. Gulyak, Vera A. Alferova, Vladimir A. Korshun & Ksenia A. Sapozhnikova. (2023) Introduction of Carbonyl Groups into Antibodies. Molecules 28:23, pages 7890.
Crossref
Crossref
Leonardo F. Ormundo, Carolina T. Barreto & Lilian R. Tsuruta. (2023) Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections. Viruses 15:11, pages 2177.
Crossref
Crossref
Moritz Thran, Marion Pönisch, Hillary Danz, Nigel Horscroft, Konstantin Ichtchenko, Saul Tzipori & Charles B. Shoemaker. (2023) Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies. Scientific Reports 13:1.
Crossref
Crossref
Jingjie Jiang, Guangyu Yang & Fuqiang Ma. (2023) Fluorescence coupling strategies in fluorescence-activated droplet sorting (FADS) for ultrahigh-throughput screening of enzymes, metabolites, and antibodies. Biotechnology Advances 66, pages 108173.
Crossref
Crossref
Ariel Tennenhouse, Lev Khmelnitsky, Razi Khalaila, Noa Yeshaya, Ashish Noronha, Moshit Lindzen, Emily K. Makowski, Ira Zaretsky, Yael Fridmann Sirkis, Yael Galon-Wolfenson, Peter M. Tessier, Jakub Abramson, Yosef Yarden, Deborah Fass & Sarel J. Fleishman. (2023) Computational optimization of antibody humanness and stability by systematic energy-based ranking. Nature Biomedical Engineering 8:1, pages 30-44.
Crossref
Crossref
Merve Arslan, Tuğçe Uluçay, Seyit Kale & Sibel Kalyoncu. (2023) Engineering of conserved residues near antibody heavy chain complementary determining region 3 (HCDR3) improves both affinity and stability. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1871:4, pages 140915.
Crossref
Crossref
Linghui Qian, Xuefen Lin, Xue Gao, Rizwan Ullah Khan, Jia-Yu Liao, Shubo Du, Jingyan Ge, Su Zeng & Shao Q. Yao. (2023) The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics. Chemical Reviews 123:12, pages 7782-7853.
Crossref
Crossref
Lei Chen, Jiansheng Lu, Rong Wang, Ying Huang, Yunzhou Yu, Peng Du, Jiazheng Guo, Xi Wang, Yujia Jiang, Kexuan Cheng, Tao Zheng & Zhixin Yang. (2023) Humanization and characterization of a murine monoclonal neutralizing antibody against human adenovirus 7. Virology 583, pages 36-44.
Crossref
Crossref
Artem Pilunov, Dmitrii S. Romaniuk, Anton Shmelev, Savely Sheetikov, Anna N. Gabashvili, Alexandra Khmelevskaya, Dmitry Dianov, Ksenia Zornikova, Naina T. Shakirova, Murad Vagida, Apollinariya Bogolyubova & Grigory A. Efimov. (2023) Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells. Cancers 15:5, pages 1592.
Crossref
Crossref
Ximin Chen, Laurence C. Chen, Mobina Khericha, Xiangzhi Meng, Emma Salvestrini, Amanda Shafer, Neha Iyer, Anya S. Alag, Yunfeng Ding, Demetri M. Nicolaou & Yvonne Y. Chen. (2023) Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR. Cancer Immunology Research 11:2, pages 150-163.
Crossref
Crossref
Andreas Evers, Shipra Malhotra, Wolf-Guido Bolick, Ahmad Najafian, Maria Borisovska, Shira Warszawski, Yves Fomekong Nanfack, Daniel Kuhn, Friedrich Rippmann, Alejandro Crespo & Vanita Sood. 2023. Genotype Phenotype Coupling. Genotype Phenotype Coupling
383
398
.
Nathaniel Pascual, Theodore Belecciu, Sam Schmidt, Athar Nakisa, Xuefei Huang & Daniel Woldring. 2023. Genotype Phenotype Coupling. Genotype Phenotype Coupling
175
212
.
Corie Y. Ralston & Joshua S. Sharp. (2022) Structural Investigation of Therapeutic Antibodies Using Hydroxyl Radical Protein Footprinting Methods. Antibodies 11:4, pages 71.
Crossref
Crossref
Marcel Walser, Jennifer Mayor & Sylvia Rothenberger. (2022) Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors. Viruses 14:10, pages 2242.
Crossref
Crossref
Xiaochen Lyu, Qichao Zhao, Julia Hui, Tiffany Wang, Mengyi Lin, Keying Wang, Jialing Zhang, Jiaqian Shentu, Paul A Dalby, Hongyu Zhang & Bo Liu. (2022) The global landscape of approved antibody therapies. Antibody Therapeutics 5:4, pages 233-257.
Crossref
Crossref
Isabella Gizzi Jiacomini, Martina Beltramino, Fanny Boursin, João Carlos Minozzo, Juliana Ferreira de Moura, Philippe Billiald, Larissa Magalhães Alvarenga & Nicolas Aubrey. (2022) An effective strategy for the humanization of antibody fragments under an accelerated timeline. International Journal of Biological Macromolecules 216, pages 465-474.
Crossref
Crossref
Priya Chouhan, Satyendra Singh, Vinita Sharma & Vijay Kumar Prajapati. (2022) Anti-IL-10 Antibody Humanization by SDR Grafting with Enhanced Affinity to Neutralize the Adverse Response of Interleukin-10. International Journal of Peptide Research and Therapeutics 28:5.
Crossref
Crossref
Xinyang Li, Jun Hong, Xiaoyan Gao, Meiniang Wang & Naibo Yang. (2022) Development and characterization of a camelid derived antibody targeting a linear epitope in the hinge domain of human PCSK9 protein. Scientific Reports 12:1.
Crossref
Crossref
Isamu Tsuji, Fue Vang, David Dominguez, Lovkesh Karwal, Ankita Sanjali, Jill A. Livengood, Edgar Davidson, Mallorie E. Fouch, Benjamin J. Doranz, Subash C. Das & Hansi J. Dean. (2022) Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function. Journal of Virology 96:11.
Crossref
Crossref
Dongjoon Ko, Eunmi Kim, Eun-Ae Shin, Seo Hee Nam, Junghwa Yoon, Jin-Sook Lee, Yunhee Lee, Sora Park, Kyungsoo Ha, So-Young Choi, Jung Weon Lee & Semi Kim. (2022) Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models. Molecular Therapy - Oncolytics 24, pages 452-466.
Crossref
Crossref
Yuan-Chin Hsieh, Jun-min Liao, Kuo-Hsiang Chuang, Kai-Wen Ho, Shih-Ting Hong, Hui-Ju Liu, Bo-Cheng Huang, I-Ju Chen, Yen-Ling Liu, Jaw-Yuan Wang, Hsiang-Lin Tsai, Yu-Cheng Su, Yen-Tseng Wang & Tian-Lu Cheng. (2022) A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Esmaeil Darvish Aminabad, Ahmad Mobed, Mohammad Hasanzadeh, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh & Farzad Seidi. (2022) Sensitive immunosensing of α-synuclein protein in human plasma samples using gold nanoparticles conjugated with graphene: an innovative immuno-platform towards early stage identification of Parkinson's disease using point of care (POC) analysis. RSC Advances 12:7, pages 4346-4357.
Crossref
Crossref
Yu-Min Chuang, Xu-Dong Tang & Erol Fikrig. (2022)
A Mosquito AgTRIO Monoclonal Antibody Reduces Early
Plasmodium
Infection of Mice
. Infection and Immunity 90:1.
Crossref
Crossref
Yuqin Niu, Jianxiang Chen & Yiting Qiao. (2022) Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe. Frontiers in Immunology 13.
Crossref
Crossref
Traian Sulea. 2022. Single-Domain Antibodies. Single-Domain Antibodies
299
312
.
Gunnar Houen. 2022. Therapeutic Antibodies. Therapeutic Antibodies
1
25
.
Zhengli Bai, Menglong Xu, Ying Mei, Tuo Hu, Panpan Zhang, Manman Chen, Wenxiu Lv, Chenchen Lu & Shuhua Tan. (2021) Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia. Biomedicines 9:12, pages 1783.
Crossref
Crossref
Claire Marks, Alissa M Hummer, Mark Chin & Charlotte M Deane. (2021) Humanization of antibodies using a machine learning approach on large-scale repertoire data. Bioinformatics 37:22, pages 4041-4047.
Crossref
Crossref
Bilian Huang, Linjing Zhu, Hongxia Wei, Haixia Shi, Doudou Zhang, Huanyun Yuan, Linlin Luan, Nan Zheng, Shijie Xu, Waqas Nawaz, Ying Hong, Xilin Wu & Zhiwei Wu. (2021) Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer. Frontiers in Immunology 12.
Crossref
Crossref
Mariam Elshiaty, Hannah Schindler & Petros Christopoulos. (2021) Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer. International Journal of Molecular Sciences 22:11, pages 5632.
Crossref
Crossref
Hirotoshi Yasui, Yuko Nishinaga, Shunichi Taki, Kazuomi Takahashi, Yoshitaka Isobe, Misae Shimizu, Chiaki Koike, Tetsuro Taki, Aya Sakamoto, Keiko Katsumi, Keisuke Ishii & Kazuhide Sato. (2021) Near-infrared photoimmunotherapy targeting GPR87: Development of a humanised anti-GPR87 mAb and therapeutic efficacy on a lung cancer mouse model. EBioMedicine 67, pages 103372.
Crossref
Crossref
Emanuel Peplau, Francesco De Rose, Andreas Eichinger, Sybille Reder, Markus Mittelhäuser, Giorgia Scafetta, Markus Schwaiger, Wolfgang A. Weber, Armando Bartolazzi, Calogero D’Alessandria & Arne Skerra. (2021) Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo. Scientific Reports 11:1.
Crossref
Crossref
Adrian Elter, Jan P. Bogen, Steffen C. Hinz, David Fiebig, Arturo Macarrón Palacios, Julius Grzeschik, Björn Hock & Harald Kolmar. (2020) Humanization of Chicken‐Derived scFv Using Yeast Surface Display and NGS Data Mining. Biotechnology Journal 16:3.
Crossref
Crossref
Jane Zveiter Moraes, Bárbara Hamaguchi, Camila Braggion, Enzo Reina Speciale, Fernanda Beatriz Viana Cesar, Gabriela de Fátima da Silva Soares, Juliana Harumi Osaki, Tauane Mathias Pereira & Rodrigo Barbosa Aguiar. (2021) Hybridoma technology: is it still useful?. Current Research in Immunology 2, pages 32-40.
Crossref
Crossref
Jaclyn M. Hoover, Elisabeth G. Prinslow, Jeffrey E. Teigler, Matthew D. Truppo & Sherry L. La Porte. 2021. Remington. Remington
417
436
.
You-Chiun Chang, Chia-Yi Kao, Hao-Cheng Tang, Meng-Sen Huang & Kurt Yun Mou. (2020) Direct Antibody Isolation on Cells Using Affinity-Tag-Guided Proximity Selection. Biochemistry 59:44, pages 4285-4293.
Crossref
Crossref
Merve Arslan, Dilara Karadag & Sibel Kalyoncu. (2020) Conformational changes in a Vernier zone region: Implications for antibody dual specificity. Proteins: Structure, Function, and Bioinformatics 88:11, pages 1447-1457.
Crossref
Crossref
Rongyuan Gao, Chithra C. Sreenivasan, Zizhang Sheng, Ben M. Hause, Bin Zhou, David E. Wentworth, Travis Clement, Dana Rausch, Colin Brunick, Jane Christopher-Hennings, Hua Wu, Christoph L. Bausch, Eddie J. Sullivan, Adam D. Hoppe, Victor C. Huber, Dan Wang & Feng Li. (2020) Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain. Journal of Virology 94:22.
Crossref
Crossref
Manali S. Sawant, Craig N. Streu, Lina Wu & Peter M. Tessier. (2020) Toward Drug-Like Multispecific Antibodies by Design. International Journal of Molecular Sciences 21:20, pages 7496.
Crossref
Crossref
Fleury Augustin Nsole Biteghe, Neelakshi Mungra, Nyangone Ekome Toung Chalomie, Jean De La Croix Ndong, Jean Engohang-Ndong, Guillaume Vignaux, Eden Padayachee, Krupa Naran & Stefan Barth. (2020) Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies. Oncotarget 11:38, pages 3531-3557.
Crossref
Crossref
Michael Ulitzka, Stefania Carrara, Julius Grzeschik, Henri Kornmann, Björn Hock & Harald Kolmar. (2020) Engineering therapeutic antibodies for patient safety: tackling the immunogenicity problem. Protein Engineering, Design and Selection 33.
Crossref
Crossref
Fleury Augustin Nsole Biteghe, Nyangone Ekome Toung Chalomie, Neelakshi Mungra, Guillaume Vignaux, Nan Gao, Aurelia Vergeade, Ambrose Okem, Krupa Naran, Jean De La Croix Ndong & Stefan Barth. (2020) Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma. Biomedicines 8:9, pages 327.
Crossref
Crossref
V. S. Rybchenko, A. A. Panina, N. V. Novoseletsky, D. S. Balabashin, S. A. Yakimov, O. N. Solopova, P. G. Sveshnikov, T. K. Aliev, D. A. Dolgikh & M. P. Kirpichnikov. (2020) Generation and Characterization of Human Interferon-beta Neutralizing Humanized Antibody. Russian Journal of Bioorganic Chemistry 46:5, pages 778-786.
Crossref
Crossref
Lukas Amon, Lukas Hatscher, Lukas Heger, Diana Dudziak & Christian H. K. Lehmann. (2020) Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy. Pharmaceutics 12:7, pages 663.
Crossref
Crossref
Claire Marks & Charlotte M. Deane. (2020) How repertoire data are changing antibody science. Journal of Biological Chemistry 295:29, pages 9823-9837.
Crossref
Crossref
Daisuke Kuroda & Kouhei Tsumoto. (2020) Engineering Stability, Viscosity, and Immunogenicity of Antibodies by Computational Design. Journal of Pharmaceutical Sciences 109:5, pages 1631-1651.
Crossref
Crossref
Sabrina Karim-Silva, Alessandra Becker-Finco, Isabella Gizzi Jiacomini, Fanny Boursin, Arnaud Leroy, Magali Noiray, Juliana de Moura, Nicolas Aubrey, Philippe Billiald & Larissa M. Alvarenga. (2020) Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential. Toxins 12:4, pages 256.
Crossref
Crossref
Manzoor A. Mir, Umar Mehraj, Bashir Ahmad Sheikh & Syed Suhail Hamdani. (2020) Nanobodies: The “Magic Bullets” in therapeutics, drug delivery and diagnostics. Human Antibodies 28:1, pages 29-51.
Crossref
Crossref
Andrew M Wollacott, Chonghua Xue, Qiuyuan Qin, June Hua, Tanggis Bohnuud, Karthik Viswanathan & Vijaya B Kolachalama. (2019) Quantifying the nativeness of antibody sequences using long short-term memory networks. Protein Engineering, Design and Selection 32:7, pages 347-354.
Crossref
Crossref
Monica L Fernández-Quintero, Martin C Heiss & Klaus R Liedl. (2019) Antibody humanization—the Influence of the antibody framework on the CDR-H3 loop ensemble in solution. Protein Engineering, Design and Selection 32:9, pages 411-422.
Crossref
Crossref
Roghayyeh Baghban, Safar Farajnia, Masoumeh Rajabibazl, Younes Ghasemi, AmirAli Mafi, Reyhaneh Hoseinpoor, Leila Rahbarnia & Maryam Aria. (2019) Yeast Expression Systems: Overview and Recent Advances. Molecular Biotechnology 61:5, pages 365-384.
Crossref
Crossref
Ekaterina O. Gubernatorova, Olga A. Namakanova, Alexei V. Tumanov, Marina S. Drutskaya & Sergei A. Nedospasov. (2019) Mouse models of severe asthma for evaluation of therapeutic cytokine targeting. Immunology Letters 207, pages 73-83.
Crossref
Crossref
Bruce A. Hay, Juan Li & Ming Guo. (2018) Vectored gene delivery for lifetime animal contraception: Overview and hurdles to implementation. Theriogenology 112, pages 63-74.
Crossref
Crossref
Naroa Serna, Laura Sánchez-García, Ugutz Unzueta, Raquel Díaz, Esther Vázquez, Ramón Mangues & Antonio Villaverde. (2018) Protein-Based Therapeutic Killing for Cancer Therapies. Trends in Biotechnology 36:3, pages 318-335.
Crossref
Crossref
Zehua Sun, Lixin Yan, Jiansong Tang, Qian Qian, Jerica Lenberg, Dandan Zhu, Wan Liu, Kao Wu, Yilin Wang & Shiqiang Lu. (2018) Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies. Virus Research 243, pages 75-82.
Crossref
Crossref
Daniela Teixeira & Maria Gonzalez-Pajuelo. 2018. Biomedical Applications of Functionalized Nanomaterials. Biomedical Applications of Functionalized Nanomaterials
67
88
.
Masaru Ishii. (2017) Immunology proves a great success for treating systemic autoimmune diseases – a perspective on immunopharmacology: IUPHAR Review 23. British Journal of Pharmacology 174:13, pages 1875-1880.
Crossref
Crossref
Bahman Akbari, Safar Farajnia, Nosratollah Zarghami, Nejat Mahdieh, Mohammad Rahmati, Shiva A. Khosroshahi, Abolfazl Barzegar & Leila Rahbarnia. (2017) Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A. Anti-Cancer Drugs 28:3, pages 263-270.
Crossref
Crossref
L.M. Alvarenga, J. de Moura & P. Billiald. 2017. Current Developments in Biotechnology and Bioengineering. Current Developments in Biotechnology and Bioengineering
97
121
.
Gang Chen, Sachdev S. Sidhu & Johan Nilvebrant. 2017. Recombinant Antibodies for Infectious Diseases. Recombinant Antibodies for Infectious Diseases
79
98
.
Konrad Krawczyk, James Dunbar & Charlotte M. Deane. 2017. Computational Protein Design. Computational Protein Design
399
416
.
Bahman Akbari, Safar Farajnia, Nosratollah Zarghami, Nejat Mahdieh, Mohammad Rahmati, Shiva Ahdi Khosroshahi & Leila Rahbarnia. (2016) Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR). Protein Expression and Purification 127, pages 8-15.
Crossref
Crossref
Hao Guo, Hao Chen, Qi Zhu, Xiaoyan Yu, Rong Rong, Siva B. Merugu, Hitesh B. Mangukiya & Dawei Li. (2016) A humanized monoclonal antibody targeting secreted anterior gradient 2 effectively inhibits the xenograft tumor growth. Biochemical and Biophysical Research Communications 475:1, pages 57-63.
Crossref
Crossref
Yaghoub Safdari, Vahideh Ahmadzadeh, Masoumeh Khalili, Hossein Zarei Jaliani, Vahid Zarei & Vahid Erfani-Moghadam. (2016) Use of Single-Chain Antibody Derivatives for Targeted Drug Delivery. Molecular Medicine 22:1, pages 258-270.
Crossref
Crossref
Kannika KhantasupWarangkana ChantimaChak SangmaKanokwan PoomputsaTararaj Dharakul. (2015) Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 34:6, pages 404-417.
Crossref
Crossref
Hiroki Akiba & Kouhei Tsumoto. (2015) Thermodynamics of antibody–antigen interaction revealed by mutation analysis of antibody variable regions. The Journal of Biochemistry 158:1, pages 1-13.
Crossref
Crossref
Andreas H. Laustsen, José María Gutiérrez, Brian Lohse, Arne R. Rasmussen, Julián Fernández, Christina Milbo & Bruno Lomonte. (2015) Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins. Toxicon 99, pages 23-35.
Crossref
Crossref
Alexander Jarasch, Hans Koll, Joerg T. Regula, Martin Bader, Apollon Papadimitriou & Hubert Kettenberger. (2015) Developability Assessment During the Selection of Novel Therapeutic Antibodies. Journal of Pharmaceutical Sciences 104:6, pages 1885-1898.
Crossref
Crossref
Jooho Roh, Sung June Byun, Youngsil Seo, Minjae Kim, Jae-Ho Lee, Songmi Kim, Yuno Lee, Keun Woo Lee, Jin-Kyoo Kim & Myung-Hee Kwon. (2015) Generation of a chickenized catalytic anti-nucleic acid antibody by complementarity-determining region grafting. Molecular Immunology 63:2, pages 513-520.
Crossref
Crossref
Jin Hong Kim, Philippe Gripon, Fidaa Bouezzedine, Mun Sik Jeong, Seung-Wook Chi, Seong-Eon Ryu & Hyo Jeong Hong. (2014) Enhanced humanization and affinity maturation of neutralizing anti‐hepatitis B virus preS1 antibody based on antigen–antibody complex structure. FEBS Letters 589:2, pages 193-200.
Crossref
Crossref
Paul J. Conroy, Ruby H.P. Law, Sarah Gilgunn, Stephen Hearty, Tom T. Caradoc-Davies, Gordon Lloyd, Richard J. O'Kennedy & James C. Whisstock. (2014) Reconciling the Structural Attributes of Avian Antibodies. Journal of Biological Chemistry 289:22, pages 15384-15392.
Crossref
Crossref
Yaghoub Safdari, Safar Farajnia, Mohammad Asgharzadeh, Kobra Omidfar & Masoumeh Khalili. (2014) humMR1, a highly specific humanized single chain antibody for targeting EGFRvIII. International Immunopharmacology 18:2, pages 304-310.
Crossref
Crossref